We are live on ! Find out more
MESO

Mesoblast

52 hedge funds and large institutions have $15.5M invested in Mesoblast in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

0.04% less ownership

Funds ownership: 0.25%0.21% (-0.04%)

2% less funds holding

Funds holding: 5352 (-1)

13% less capital invested

Capital invested by funds: $17.9M → $15.5M (-$2.39M)

47% less call options, than puts

Call options by funds: $3.23M | Put options by funds: $6.14M

Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
0.91%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
15
Reduced
13
Closed
12
Calls
$3.23M
Puts
$6.14M
Net Calls
-$2.91M
Net Calls Change
+$3.06M

MESO Hedge Fund Activity: Q1 2021 in Review

52 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q1 2021, worth a combined $15.5M — down 13% from $17.9M a quarter earlier.

Fund positioning in MESO was balanced in Q1 2021: 12 funds opened new positions, 12 closed out, 15 added to existing stakes and 13 trimmed.

The largest buyer was Cetera Advisor Networks, adding an estimated $831K. The largest seller was Tikvah Management, exiting entirely with an estimated $1.21M sold.

  • 52 institutional investors held Mesoblast (MESO) as of Q1 2021, down from 53 in Q4 2020.
  • Funds reported $15.5M of Mesoblast stock for Q1 2021, down 13% quarter-over-quarter.
  • 12 funds opened new Mesoblast positions in Q1 2021 and 12 closed out, a net change of 0 holders.
  • The largest Mesoblast buyer in Q1 2021 was Cetera Advisor Networks, an estimated $831K added.
  • The largest Mesoblast seller in Q1 2021 was Tikvah Management, an estimated $1.21M sold.

Based on aggregated 13F filings for Q1 2021.